Meta-Analysis
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10208-10221
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10208
Table 3 Pooled results of inflammatory factors and complications
Outcomes
Categories
Number of records
OR/WMD and 95%CI
P
Heterogeneity with groups (I2)
Phet value
Inflammatory factors
C-reactive protein (pre)3-0.28, [-1.14, 0.58]0.5372%0.03
C-reactive protein (post)3-10.06, [-17.39, -2.73]0.00798.0%< 0.001
Tumor necrosis factor-α (pre)2-0.21, [-1.32, 0.90]0.710.0%0.68
Tumor necrosis factor-α (post)27.70, [-8.47, -6.93]< 0.00199.0%< 0.001
Interleukin 6 (pre)3-0.11, [-1.04, 0.82]0.816.0%0.34
Interleukin 6 (post)3-9.78, [-10.69, -8.88]< 0.00199.0%< 0.001
Complications
Intestinal obstruction40.19, [0.05, 0.79]0.0200.0%0.95
Abdominal infection20.10, [0.01, 0.83]0.0300.0%0.44
Urinary tract infection30.27, [0.04, 1.65]0.1600.0%0.97